Vyant Bio, OrganoTherapeutics Will Use Organoids for New Therapies
Vyant Bio and OrganoTherapeutics are teaming up to speed the discovery of new candidates for treating Parkinson’s…
Articles by Patricia Inácio, PhD
Dosing Begins in Phase 3 Trial of PET Agent for Parkinsonian Syndromes
The first patient has been dosed in a Phase 3 trial testing GE Healthcare’s new dopamine transporter…
Trial of Bradykinesia Stem Cell Therapy Now Dosing Last Group
IMAC Holdings has started dosing the third and final group of participants in a Phase 1 clinical trial assessing…
PET Tracer ACI-12589 Captures Protein Clumps in Living Brain
A positron emission tomography (PET) tracer for the alpha-synuclein protein, whose damaging clumps mark Parkinson’s, captured its toxic aggregates in…
AI-Powered Device JOGO-Gx May Ease Tremors
JOGO-Gx, a device powered by an artificial intelligence-driven mobile app and wearable sensors, has shown early positive signs as a…
Researchers Get $1.37M Grant to Assess Early Diagnostic Test
Australian researchers have received a $1.37-million grant to assess the potential of an early diagnostic test for Parkinson’s disease.
NIH $2.8M Grant Funds Work Into Differing Alpha-synuclein Strains
A $2.8 million National Institutes of Health (NIH) grant will fund research into the molecular mechanisms underlying multiple system atrophy (MSA),…
Parkinson’s Foundation Recognizes Nurses, Physical Therapists
The Parkinson’s Foundation announced six winners of this year’s Nurse Faculty Award and Physical Therapy Faculty Award. Each winner receives up to $10,000…
New Partners to Develop Therapies to Ease Brain Inflammation
Parkinson’s UK and Domainex are teaming up to develop small molecules aimed at lessening chronic brain inflammation and…
$3.2M Grant to Advance Work Into Serotonin, Its Role in Movement
A National Institutes of Health (NIH) grant worth $3.2 million will further research into how the rewiring of serotonin-producing nerve…